These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4150555)

  • 1. Proceedings: Bioavailability of salicylamide from tablets.
    Mulley BA; Rye RM; Shaw P
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:150P. PubMed ID: 4150555
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between the rate of dissolution and absorption of salicylamide from tablet and suspension dosage forms.
    Bates TR; Lambert DA; Johns WH
    J Pharm Sci; 1969 Dec; 58(12):1468-70. PubMed ID: 5353261
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of salicylamide elimination in man.
    Levy G; Matsuzawa T
    J Pharmacol Exp Ther; 1967 May; 156(2):285-93. PubMed ID: 6026259
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of sulfate formation in biotransformation of salicylamide in man.
    Levy G; Matsuzawa T
    J Pharm Sci; 1966 Feb; 55(2):222-3. PubMed ID: 5923280
    [No Abstract]   [Full Text] [Related]  

  • 5. The construction and uses of factorial designs in the preparation of solid dosage forms. Part 3. Effect of temperature and time on the mechanical properties of sintered tablets.
    El-Banna HM; Boraie N; El-Shibini HA
    Pharmazie; 1981 Nov; 36(11):772-5. PubMed ID: 7323126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The construction and uses of factorial designs in the preparation of solid dosage forms.
    El-Banna HM; Boraie N; El-Shibini HA
    Pharmazie; 1981 Dec; 36(12):819-23. PubMed ID: 7330083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors influencing the bioavailability of drugs in the form of tablets].
    Cid E
    Pharm Acta Helv; 1974; 49(9-10):285-92. PubMed ID: 4462136
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium salicylamide: relative bioavailability and subjective effects.
    Fleckenstein L; Mundy GR; Horovitz RA; Mazzullo JM
    Clin Pharmacol Ther; 1976 Apr; 19(4):451-8. PubMed ID: 1269196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution rates of caffeine and salicylamide from tablets.
    Nerlo H; Czarnecki W; Dul R
    Pol J Pharmacol Pharm; 1974; 26(5):549-53. PubMed ID: 4427817
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rectal absorption of salicylamide in suppositories in gelatin capsules].
    Natalizi G
    Boll Chim Farm; 1966 Jul; 105(7):545-52. PubMed ID: 6003411
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of the acetylsalicylic acid tablets registered in Finland.
    Perälä-Suominen A
    Ann Clin Res; 1974; 6(0):suppl 11:26-33. PubMed ID: 4855462
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioavailability and digoxin.
    N Z Med J; 1972 Sep; 76(484):203. PubMed ID: 4508750
    [No Abstract]   [Full Text] [Related]  

  • 13. [The significance of the form of preparation for the degree of adsorption of medical charcoal].
    Otto U; Stenberg B
    Lakartidningen; 1973 Aug; 70(31):2729-30. PubMed ID: 4786756
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorescence of boron complexes. VII. Fluorometric determination of salicylamide.
    Shibazaki T
    Chem Pharm Bull (Tokyo); 1978 Jul; 26(7):1985-9. PubMed ID: 688530
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of digoxin tablets.
    Lindenbaum J
    Pharmacol Rev; 1973 Jun; 25(2):229-37. PubMed ID: 4581042
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: The effect of formulation on the availability of sulphadiazine.
    Garnham JC; Raymond K; Shotton E; Turner P
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:151P-152. PubMed ID: 4150557
    [No Abstract]   [Full Text] [Related]  

  • 17. Recognition of variable bioavailability as an international problem: a review of the earlier studies.
    Munro-Faure AD; Fowle AS; Fox J; Johnson BF; Lader S
    Postgrad Med J; 1974 Nov; 50 Suppl 6():14-8. PubMed ID: 4459882
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioavailability of peroral dosage forms.
    Ritschel WA
    Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
    [No Abstract]   [Full Text] [Related]  

  • 19. Salicylamide-Glucuronide formation in children with favism and in their parents.
    Cutillo S; Costa S; Vintuleddu MC; Meloni T
    Acta Haematol; 1976; 55(5-2):296-9. PubMed ID: 821294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Influence of formulation on absorption and clinical effect of digoxin.
    Shaw TR; Howard MR; Hamer J
    Br Heart J; 1974 Apr; 36(4):400. PubMed ID: 4841478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.